4Bohan A, Peter JB. Polymyo sitis and dermatomyositis ( first of twoparts) [J].N Engl J Med, 1975,292(7) :344-347.
5Bohan A,Peter JB. Polymyo sitis and dermatomyositis( seco nd o f two parts) [J].N Eng 1 J Med,1975 ,292(8) :403-407.
6Scola RH, Wemeck LC,Prevedello DM,et al. Diagnosis of dermato-myositis and polymyositis ; a study of 102 cases [ J ] . Arq Neurop-siquiatr,2000,58(36) :789-99.
7Mir6 0,Laguno M,Alonso JR,et al. Clinical course of idiopathic in-flammatory myopathies: complications,survival and prognostic factors[J]. Med Clin (Bare) ,1999,112(14) :521-526.
8Haas RH, Dyck RF, Dubowitz V, et al. C-reactive protein in child-hood dermatomyositis[ J] , Ann Rheum Dis, 1982 ,41 (5 ) :483-485.
9Gabay C,Gay-Croisier F,Roux-Lombard P,et al. Elevated serum lev-els of interleukin-1 receptor antagonist in polymyositis/dermatomyo-sitis. A biologic marker of disease activity with a possible role in thelack of acute-phase protein response[ J]. Arthritis Rheum, 1994,37(12) :1744-1751.
10Szalai AJ. C-Reactive Protein ( CRP) and Autoimmune Disease:Facts and Conjectures[ J]. Clin Dev Immunol,2004 ,11 (3-4) :221-226.
